How much funding has Oleander Medical Technologies raised?

Oleander Medical Technologies has disclosed $2.7M raised across 2 rounds.

Where is Oleander Medical Technologies headquartered?

Oleander Medical Technologies is headquartered in Baton Rouge, US.

Oleander Medical Technologies

Baton Rouge, US · Louisiana LLC

Find your way into Oleander Medical Technologies

Paths you didn't know you had: your email and LinkedIn already hold routes to the Oleander Medical Technologies team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Oleander Medical Technologies develops Targeted Osmotic Lysis, a medical technology approach for treating cancer in animals. The company works with veterinary hospitals and regulatory consultants to advance its therapeutic platform.

Biotech Healthtech Medical Devices

Founders & leadership

Paige R. Miller President & CEOPaige R. Miller is President of Oleander Medical Technologies, which develops Targeted Osmotic Lysis for treating cancer in animals. She has experience leading innovative projects through financial and regulatory processes.

Harry J Gould IIIChief Medical Officer

Henry J. MillsChief Business Officer

Dennis Paul Managing Member and Chief Science OfficerDr. Dennis Paul is a co-inventor of Oleander Medical Technologies' Targeted Osmotic Lysis platform for cancer treatment, with expertise in analgesic mechanisms, drug-drug interactions, and radiation safety.

Harry GouldCo-inventor (Dr.), Louisiana State University

Reported raises · per SEC filings

Form D private placements

$2.7M disclosed across 2 rounds · 2017–2024

▶$500KraisedJul 2024 · 4 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Paige R. MillerExecutive Officer
Harry J Gould IIIExecutive Officer
Henry J. MillsExecutive Officer
Dennis PaulExecutive Officer

Offering amount: $5M
Amount sold: $500K
Minimum investment: $50K
First sale: Jun 2024
Incorporated: Limited Liability Company, Louisiana
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$2.2MraisedSep 2020 · 19 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Henry J MillsExecutive Officer

Offering amount: $4M
Amount sold: $2.2M
Minimum investment: $50K
First sale: Jan 2017
Incorporated: Limited Liability Company, Louisiana
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Oleander Medical Technologies do?: Oleander Medical Technologies develops Targeted Osmotic Lysis, a medical technology approach for treating cancer in animals. The company works with veterinary hospitals and regulatory consultants to advance its therapeutic platform.
How much funding has Oleander Medical Technologies raised?: Oleander Medical Technologies has disclosed $2.7M raised across 2 rounds.
Where is Oleander Medical Technologies headquartered?: Oleander Medical Technologies is headquartered in Baton Rouge, US.